PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
07-Jan-2026 The Assistance Fund Opens New Program for Myeloproliferative Neoplasms ACCESS Newswire
07-Jan-2026 Sarepta Therapeutics Announces Submission of Clinical Trial Application for SRP-1005, its Investigational Treatment for Huntington’s Disease Businesswire
07-Jan-2026 Nuveen Multi-Asset Income Fund Announces Update to Portfolio Management Team Businesswire
07-Jan-2026 FRMI BREAKING NEWS: Fermi Inc. Announces Cancellation of $150 million Customer Agreement Triggering Securities Class Action after Stock Drops Over 33% -- Investors Urged to Contact BFA Law Businesswire
07-Jan-2026 MEDPHARM ANNOUNCES SUCCESSFUL US FDA INSPECTION OF ITS CGMP COMMERCIAL MANUFACTURING FACILITY IN DURHAM, NORTH CAROLINA MedPharm
07-Jan-2026 Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions Businesswire
07-Jan-2026 Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference Businesswire
07-Jan-2026 Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference Businesswire
07-Jan-2026 Digital Validation and Cloud Assurance Modular Course for Practitioners: Validating SaaS, PaaS and Automated Pipelines under CSA - ResearchAndMarkets.com Businesswire
07-Jan-2026 Digital Validation and Cloud Assurance Modular Course for Practitioners: Validating SaaS, PaaS and Automated Pipelines under CSA - ResearchAndMarkets.com Businesswire
07-Jan-2026 eGenesis to Present at 44th Annual J.P. Morgan Healthcare Conference Businesswire
07-Jan-2026 ReAlta Life Sciences Announces Appointment of Jonathan Rigby to Board of Directors Businesswire
07-Jan-2026 Forlong Biotechology Announced Activation of Phase Ib/II Study of FL115 (IL-15 Superagonist) in combination with anti-PD-1 Antibody for Patients with Advanced Solid Tumor and Acceptance of IND for FL115 Subcutaneous Injection by NMPA Businesswire
07-Jan-2026 Nocion Therapeutics Extends Series B Financing to $93 Million to Support Late-Stage Development of Taplucainium in Chronic Cough Businesswire
07-Jan-2026 bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation Businesswire
07-Jan-2026 Kelonia Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for KLN-1010, an in vivo BCMA CAR-T Therapy for Relapsed and Refractory Multiple Myeloma Businesswire
07-Jan-2026 Truvian Appoints Renowned Physician-Scientist and Diagnostic Innovator Dr. Michael Mina as Chief Medical and Strategy Officer Businesswire
07-Jan-2026 Horizon3.ai Appoints Andres Botero as Chief Marketing Officer to Drive Strategic Growth and Category Leadership Businesswire
07-Jan-2026 Ascidian Therapeutics and Forge Biologics Announce Manufacturing Partnership to Advance RNA Editing Therapy for Stargardt Disease Businesswire
07-Jan-2026 BigHat Biosciences Partners With Lilly to Advance Machine-Learning-Enabled Biologics Discovery Through Lilly TuneLab Businesswire